Having trouble accessing articles? Reset your cache.

Zibotentan: Phase III data

The Phase III Study 14 trial in 594 patients with metastatic CRPC showed that once-daily 10

Read the full 165 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE